About miBiome Therapeutics
miBiome Therapeutics is a company based in Mumbai (India) founded in 2019 by Ravi Shroff and Gautam Das. It operates as a B2B. miBiome Therapeutics offers products and services including DNA Reading, Scientific Consulting, and Computational Analytics. miBiome Therapeutics operates in a competitive market with competitors including Macrogen, Genewiz, BGI, Transnetyx and Acclinate, among others.
- Headquarter Mumbai, India
- Founders Ravi Shroff, Gautam Das
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website mibiome.com
- Social LinkedIn X Facebook
- Legal Name Mibiome Therapeutics Llp
- Date of Incorporation 16 May, 2019
- Jurisdiction Jogeshwart West Mumbai, Maharashtra, India
- Annual Revenue$45.73 K (USD)0as on Mar 31, 2021
Associated legal entities of miBiome Therapeutics
miBiome Therapeutics operates through Mibiome Therapeutics Llp (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Mibiome Therapeutics Llp CIN AAP-3186 | Active | 16 May 2019 | Mumbai, Maharashtra | – | – | 2 | View details |
Products & Services of miBiome Therapeutics
miBiome Therapeutics offers a comprehensive portfolio of products and services, including DNA Reading, Scientific Consulting, and Computational Analytics.
Sequences DNA for understanding life, disease, and environment.
Provides expert guidance on genomic sequencing processes.
Utilizes software for in-depth biological data interpretation.
Board of directors of Mibiome Therapeutics Llp (miBiome Therapeutics)
Mibiome Therapeutics Llp is the primary company behind miBiome Therapeutics. The board of Mibiome Therapeutics Llp currently have 2 directors; the longest-serving is Ravi Ashwin Shroff, appointed in 2019. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Ravi Ashwin Shroff DIN 00033505 | Designated Partner | 16 May 2019 | 7 yrs 4 mo | Mibiome Therapeutics Llp |
| Gautam Das DIN 08961168 | Designated Partner | 14 Nov 2020 | 5 yrs 10 mo | Mibiome Therapeutics Llp |
People of miBiome Therapeutics
2 people are tracked at miBiome Therapeutics (2 in leadership).
| Name | Role | Group |
|---|---|---|
| Co-Founder | Leadership | |
| Co-Founder | Leadership |
Complete people profiles for miBiome Therapeutics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Competitors of miBiome Therapeutics
miBiome Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Macrogen, Genewiz, BGI, Transnetyx and Acclinate, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| macrogen.com | 1997 | Seoul, South Korea | – | – | Next-generation sequencing and genomics services are provided globally. | |
| genewiz.com | 1999 | South Plainfield, United States | – | 452 | Genomic services are provided for the life sciences industry. | |
| bgi.com | 1999 | Shenzhen, China | – | 25 | BGI is engaged in genomics and precision medicine solutions. | |
| transnetyx.com | 2000 | Memphis, United States | – | 150 | Automated genotyping services for murine cell lines are developed. | |
| acclinate.com | 2020 | Birmingham, United States | $11.99M | 43 | Clinical trial services are provided to the biopharma sector. | |
| tataa.com | 2001 | Gothenburg, Sweden | – | – | Molecular analysis services for research and drug development are offered. | |
| acrannolife.com | 2014 | Chennai, India | $1.9M | 24 | Genomic services are provided for clinical research and applications. | |
| cosmosid.com | 2008 | Rockville, United States | $7.32M | 31 | Next-generation sequencing technologies for microorganism detection are developed. | |
| stabvida.com | 2001 | – | – | – | Provider of research services in molecular biology and genomics to academia and industry |
Detailed competitors of miBiome Therapeutics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to miBiome Therapeutics
10 companies that operate in the same segment as miBiome Therapeutics (Clinical Genomics), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
CAR T-cell and T-cell receptor immunotherapies for cancer are developed. | 2013 | Seattle, Washington, United States | USD 316.67 M | – | 520 | |
Panomic profiling technologies are developed for cancer precision medicine. | 1996 | Irving, Texas, United States | USD 1.23 B | – | 1,339 | |
Genomics-based diagnostic tests for cancer are provided. | 2010 | Cambridge, Massachusetts, United States | USD 96.5 M | – | – | |
Digital molecular biology analytics are developed for disease management. | 2012 | Carlsbad, California, United States | USD 95.02 M | – | 46 | |
Diagnostic tests for cancer prognosis are provided. | 2008 | Friendswood, Texas, United States | USD 61.97 M | USD 344.23 M | 761 | |
Genomic database for clinical research is provided. | 2015 | San Francisco, California, United States | USD 435 M | – | – | |
Genomic sequencing and diagnosis software is provided for healthcare. | 2011 | Menlo Park, California, United States | USD 87.3 M | USD 69.65 M | 229 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about miBiome Therapeutics
miBiome Therapeutics was founded in 2019.
miBiome Therapeutics is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Annual revenue of miBiome Therapeutics is $45.73K as on Mar 31, 2021.
miBiome Therapeutics specializes in genomic services, including DNA sequencing, scientific consulting, and computational analytics. They assist academics and commercial clients by delivering advanced technology for genetic research and applications. Based in Mumbai, India, the company focuses on improving accessibility and efficiency in genomics, processing samples and data to drive innovations in health and biotechnology.
miBiome Therapeutics offers DNA Reading, Scientific Consulting, and Computational Analytics.
miBiome Therapeutics operates through Mibiome Therapeutics Llp.
The legal entities of miBiome Therapeutics currently have 2 directors, including Gautam Das, Ravi Ashwin Shroff.